"Medical research for new medications, devices, and procedures for a variety of diseases"

During the past decade, Center for Advanced Research & Education conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 8 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 8 clinical trials were completed. i.e. 47.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Center for Advanced Research & Education" #1 sponsor was "CytoDyn, Inc." with 4 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Pfizer" with 3 trials sponsored and "Radius Health, Inc." with 3 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Center for Advanced Research & Education" #1 collaborator was "Alzheimer's Association" with 1 trials as a collaborator, "Amarex Clinical Research" with 1 trials as a collaborator, "Clinilabs, Inc." with 1 trials as a collaborator, "Clinipace Worldwide" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Center for Advanced Research & Education" are "Alzheimer Disease" (6 trials), "Coronavirus Disease 2019" (3 trials), "Covid19" (2 trials), "Osteoarthritis, Hip" (2 trials) and "Osteoarthritis, Knee" (2 trials). Many other conditions were trialed in "Center for Advanced Research & Education" in a lesser frequency.

Most popular intervention types in "Center for Advanced Research & Education" are "Drug" (20 trials), "Biological" (4 trials), "Other" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Gantenerumab" (4 trials), "Leronlimab (700mg)" (3 trials), "Placebos" (3 trials) and "Abaloparatide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Center for Advanced Research & Education" are 21 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Center for Advanced Research & Education". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Center for Advanced Research & Education, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Center for Advanced Research & Education, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".